Sangamo Therapeutics, Inc. Share Price
Stocks
SGMOQ
US8006771062
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0710 USD | -2.74% |
|
+6.29% | -82.69% |
| 06-23 | Eli Lilly, Astellas Enter Into Asset Sale Agreements With Sangamo Therapeutics | MT |
| 06-23 | Sangamo Therapeutics, Inc. Filed for Bankruptcy | CI |
| Market Cap | 30.24M 26.53M 24.57M 22.61M 42.76M 2.89B 43.59M 293M 115M 1.42B 114M 111M 4.91B | P/E 2024 |
-2.1x | P/E 2025 | -0.96x |
|---|---|---|---|---|---|
| Enterprise Value | 36.09M 31.65M 29.32M 26.98M 51.02M 3.45B 52.02M 349M 137M 1.7B 136M 133M 5.86B | EV / Sales 2024 |
3.49x | EV / Sales 2025 | 3.72x |
| Free-Float |
98.24% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Sangamo Therapeutics, Inc.
| 1 day | -0.41% | ||
| 1 week | +6.29% | ||
| Current month | +34.88% | ||
| 1 month | -55.94% | ||
| 3 months | -71.58% | ||
| 6 months | -83.21% | ||
| Current year | -82.69% |
| 1 week | 0.06 |  | 0.1 |
| 1 month | 0.03 | | 0.2 |
| Current year | 0.03 | | 0.6 |
| 1 year | 0.03 | | 0.77 |
| 3 years | 0.03 | | 3.18 |
| 5 years | 0.03 | | 11.49 |
| 10 years | 0.03 | | 27.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 63 | 31/05/2016 |
Nikunj Jain
DFI | Director of Finance/CFO | 47 | 02/02/2026 |
Gregory Davis
CTO | Chief Tech/Sci/R&D Officer | - | 16/11/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Peg Horn
BRD | Director/Board Member | 63 | 14/12/2022 |
James Meyers
BRD | Director/Board Member | 60 | 21/11/2019 |
H. Parker
CHM | Chairman | 70 | 31/05/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-24 | Tax | Executive/Senior Manager | -4,036 | 0.0010% | ||
| 05-24 | Tax | Chief Executive Officer | -12,613 | 0.0030% | ||
| 05-24 | Tax | General Counsel | -4,036 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.74% | +6.29% | -85.46% | -94.36% | 30.24M | |
| -2.48% | -2.22% | +55.85% | +79.12% | 53.54B | |
| -0.42% | -6.87% | +55.19% | +126.47% | 54.18B | |
| +0.11% | -3.15% | +7.26% | +430.53% | 23.66B | |
| -1.13% | -5.61% | -19.82% | -17.78% | 22.78B | |
| +2.36% | +3.86% | +42.80% | -6.60% | 19.54B | |
| -2.22% | -1.45% | +36.22% | -28.80% | 17.82B | |
| -2.72% | -4.04% | +187.08% | +362.09% | 16.01B | |
| -1.15% | -3.07% | +45.33% | +654.85% | 15.37B | |
| -0.92% | -2.35% | +22.29% | +187.47% | 14.09B | |
| Average | -0.92% | -0.78% | +34.68% | +169.30% | 23.7B | |
| Weighted average by Cap. | -1.05% | -1.99% | +47.20% | +163.39% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 57.8M 50.7M 46.95M 43.2M 81.72M 5.53B 83.31M 560M 219M 2.72B 217M 212M 9.38B | 39.55M 34.69M 32.13M 29.56M 55.92M 3.79B 57.01M 383M 150M 1.86B 149M 145M 6.42B |
| Net income | -97.94M -85.9M -79.56M -73.21M -138M -9.37B -141M -948M -372M -4.6B -368M -360M -15.9B | -123M -108M -99.87M -91.89M -174M -11.77B -177M -1.19B -467M -5.78B -462M -452M -19.95B |
| Net Debt | -11.35M -9.96M -9.22M -8.49M -16.05M -1.09B -16.36M -110M -43.11M -534M -42.63M -41.7M -1.84B | 5.85M 5.13M 4.75M 4.37M 8.27M 560M 8.43M 56.61M 22.2M 275M 21.96M 21.48M 949M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | US$0.0710 | -2.74% | 477,766 |
| 13/07/26 | US$0.0730 | -27.00% | 3,203,632 |
| 10/07/26 | US$0.1000 | +19.05% | 4,721,267 |
| 09/07/26 | US$0.0840 | +27.27% | 8,025,829 |
| 08/07/26 | US$0.0660 | -3.44% | 916,830 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SGMOQ Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition